Natixis Advisors LLC Acquires 331 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Natixis Advisors LLC lifted its holdings in Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 1.1% in the third quarter, HoldingsChannel reports. The fund owned 31,711 shares of the real estate investment trust’s stock after buying an additional 331 shares during the period. Natixis Advisors LLC’s holdings in Omega Healthcare Investors were worth $1,291,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. raised its position in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 516 shares during the last quarter. Versant Capital Management Inc bought a new position in shares of Omega Healthcare Investors during the second quarter valued at approximately $26,000. DiNuzzo Private Wealth Inc. purchased a new stake in Omega Healthcare Investors in the third quarter worth $33,000. V Square Quantitative Management LLC boosted its holdings in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after acquiring an additional 323 shares in the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at $48,000. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Up 1.7 %

Shares of OHI opened at $40.77 on Wednesday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The stock has a market capitalization of $11.01 billion, a price-to-earnings ratio of 29.98, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The business’s 50 day simple moving average is $40.61 and its 200-day simple moving average is $37.19.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.57%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on OHI. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research note on Thursday, October 31st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Berenberg Bank started coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price for the company. Truist Financial lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Finally, Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Hold” and an average price target of $40.00.

Read Our Latest Stock Analysis on OHI

Insiders Place Their Bets

In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

About Omega Healthcare Investors

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Read More

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.